TITLE

STILL NO NATIVE U.S. CASES OF MAD COW-LIKE DISEASE

PUB. DATE
March 2003
SOURCE
Clinical Infectious Diseases;3/15/2003, Vol. 36 Issue 6, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on the concerns about widening human exposure to variant Creutzfeldt-Jacob disease (vCJD) in elk and deer in the U.S. Formation of a committee at the Institute of Medicine to look into the matter; Fear of transfer of chronic wasting disease from animals to humans; Suggestions of the U.S. Centers for Disease Control and Prevention on the issue; Method of killing vCJD strains on surgical tools.
ACCESSION #
9424004

 

Related Articles

  • The pathogenesis of transmissible spongiform encephalopathy: routes to the brain and the erection of therapeutic barricades. Brown, P. // Cellular & Molecular Life Sciences;Feb2001, Vol. 58 Issue 2, p259 

    Classical and modern studies of the pathogenesis of transmissible spongiform encephalopathy are reviewed, with particular attention paid to recent investigations of the routes of neuroinvasion. In various experimental models, a heirarchy of paths to the brain includes direct neural transit from...

  • Chronic Wasting Disease and Potential Transmission to Humans. Belay, Ermias D.; Maddox, Ryan A.; Williams, Elizabeth S.; Miller, Michael W.; Gambetti, Pierluigi; Schonberger, Lawrence B. // Emerging Infectious Diseases;Jun2004, Vol. 10 Issue 6, p977 

    Chronic wasting disease (CWD) of deer and elk is endemic in a tri-corner area of Colorado, Wyoming, and Nebraska, and new foci of CWD have been detected in other parts of the United States. Although detection in some areas may be related to increased surveillance, introduction of CWD due to...

  • Creutzfeldt-Jakob disease: The Canadian situation. Stratton, Elizabeth // CMAJ: Canadian Medical Association Journal;11/15/97, Vol. 157 Issue 10, p1405 

    Looks at the health problem in Canada of Creutzfeldt-Jakob disease (CJD). The number of deaths and those affected; The concern that blood is a possible risk of transmission of CJD; The coordination of intensive surveillance for CJD in Canada; The contact point for information about CJD.

  • Blood products recalled.  // FDA Consumer;Mar1995, Vol. 29 Issue 2, p3 

    Informs about the recall of some blood and plasma products because of possible contamination with a virus-like agent that is thought to cause a rare neurological disease. Actions by the American Red Cross, in cooperation with Baxter Healthcare Corp.; Creutzfeldt-Jakob disease.

  • Rise in CJD is not a true increase. Boulton, Alison // BMJ: British Medical Journal (International Edition);8/17/96, Vol. 313 Issue 7054, p383 

    Reports on the rise of Creutzfeldt-Jakob disease (CJD) in Great Britain. Clinical manifestations of CJD; Association with bovine spongiform encephalopathy; Attribution to the increase in the number of cases of CJD.

  • Surveillance for Creutzfeldt-Jakob disease--United States. Reingold, A.; Starr, M. // MMWR: Morbidity & Mortality Weekly Report;8/9/1996, Vol. 45 Issue 31, p1 

    Presents results of a survey on Creutzfeldt-Jakob disease (CJD) in the United States by the Center for Disease Control's National Center for Health Statistics. Mortality; Identification of persons who died of CJD; Clinical and neuropathological reviews of patients.

  • More CJD.  // New Scientist;6/08/96, Vol. 150 Issue 2033, p13 

    Reports on the discovery of more possible cases of the new strain of Creutzfeldt-Jakob disease (CJD) that sparked Great Britain's mad cow disease crisis.

  • Creutzfeldt-Jakob verdict may prompt new claims. Carr, Kimberly // Nature;11/11/1993, Vol. 366 Issue 6451, p98 

    Reports on cases of Creutzfeldt-Jakob disease contracted as a result of treatment with contaminated human growth hormone. Treatment with pituitary growth hormone derived from cadavers; Problems of contaminated growth hormone in Great Britain and France.

  • British families win compensation over CJD deaths. Dyer, Clare // BMJ: British Medical Journal (International Edition);11/29/97, Vol. 315 Issue 7120, p1401 

    Reports on the victorious compensation lawsuit of families of British patients who died from Creutzfeldt Jakob disease as a result of treatment with human growth hormone as children. Number of fatalities from the disease from 1959 to 1985; Families eligible for compensation; Lawsuit filed by...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics